CBD of Denver Reports €50K October Revenue as BioCannabis Deal Advances
CBD of Denver reported preliminary, unaudited revenue of about €35K in September 2026 and €50K in October 2026 from B2B hemp sales. The company said its BioCannabis share exchange is progressing and cited new international supply contracts.
CBD of Denver, Inc. said its BioCannabis share exchange is progressing and reported preliminary, unaudited revenue of about €35K in Sept 2026 and €50K in Oct 2026 from B2B hemp sales, alongside new international supply contracts.Material DetailsContext by AI AnalystThis is an early-stage operationa…